Table 3.
Adverse events as assessed by CTCAE v4.03 after first and after overall CS-PHP
| After 1st CS-PHP | Overall | |||
|---|---|---|---|---|
| n | % | n | % | |
| Platelet concentrate | 12 | 20.3 | 18 | 30.0 |
| Erythrocyte concentrate | 11 | 18.6 | 19 | 31.7 |
| Grade 3 thrombopenia | 15 | 25.0 | 28 | 46.7 |
| Grade 4 thrombopenia | 14 | 23.3 | 20 | 33.3 |
| Grade 3 anemia | 19 | 31.7 | 26 | 43.3 |
| Grade 4 anemia | 0 | 0 | 1 | 1.7 |
| Grade 3 leucopenia | 4 | 6.7 | 8 | 13.3 |
| Grade 4 leucopenia | 7 | 11.7 | 11 | 18.3 |
| Grade 3 AST increase | 11 | 18.3 | 20 | 33.3 |
| Grade 4 AST increase | 7 | 11.7 | 9 | 15.0 |
| Grade 3 ALT increase | 4 | 6.7 | 12 | 20.0 |
| Grade 4 ALT increase | 2 | 3.3 | 4 | 6.7 |
| Grade 3 hyperbilirubinemia | 5 | 8.3 | 8 | 13.6 |
| Grade 4 hyperbilirubinemia | 1 | 1.7 | 1 | 1.7 |
| Grade 3 hypoalbuminemia | 4 | 8.7 | 8 | 15.4 |
| Grade 4 hypoalbuminemia | 0 | 0 | 0 | 0 |